DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Dusigitumab
Dusigitumab
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
IGF2 Mediates Resistance to Isoform-Selective-Inhibitors of the PI3K in HPV Positive Head and Neck Cancer
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
Therapeutic Targeting of the IGF Axis
2017 Immuno-Oncology Medicines in Development
The Two Tontti Tudiul Lui Hi Ha Unit
(12) Patent Application Publication (10) Pub. No.: US 2017/0172932 A1 Peyman (43) Pub
WO 2016/176089 Al 3 November 2016 (03.11.2016) P O P C T
Immune-Related Genes: Potential Regulators and Drug Therapeutic Targets in Hypertrophic Cardiomyopathy
The IGF-II–Insulin Receptor Isoform-A Autocrine Signal in Cancer: Actionable Perspectives
(INN) for Biological and Biotechnological Substances
Identification of Key Genes and Pathways in Scleral Extracellular
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
WO 2017/176762 Al 12 October 2017 (12.10.2017) P O P C T
(INN) for Biological and Biotechnological Substances
Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies
Top View
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
N° 18380 A61k 31/5377 (2018.01) A61p 35/02 (2018.01)
6.6.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma
(12) Patent Application Publication (10) Pub. No.: US 2017/0173267 A1 Ashmead Et Al
Supplementary Tables and Figures Section 1. Distribution of CDR-H3
International Nonproprietary Names for Pharmaceutical Substances [Off
(2006.01) C07d 413/14
( 12 ) Patent Application Publication
Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
Disrupting Insulin and IGF Receptor Function in Cancer
Us 2019 / 0202839 A1
QSAR Model Development for Early Stage Screening of Monoclonal Antibody Therapeutics to Facilitate Rapid Developability
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
WO 2013/119960 A2 15 August 2013 (15.08.2013) P O P C T
(INN) for Biological and Biotechnological Substances
Targeting Obesity-Related Dysfunction in Hormonally Driven Cancers